J. W. Bartges, Chronic kidney disease in dogs and cats. The Veterinary Clinics of North America, Small Animal Practice, vol.42, pp.669-692, 2012.

Y. Benjamini and Y. Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society, Series B (Methodological), vol.57, pp.289-300, 1995.

F. Boizard, V. Brunchault, P. Moulos, B. Breuil, J. Klein et al., A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome, Scientific Reports, vol.6, p.34453, 2016.

S. A. Brown, D. R. Finco, W. A. Crowell, D. C. Choat, and L. G. Navar, Single-nephron adaptations to partial renal ablation in the dog, The American Journal of Physiology, vol.258, pp.495-503, 1990.

M. Dakna, K. Harris, A. Kalousis, S. Carpentier, W. Kolch et al., Addressing the challenge of defining valid proteomic biomarkers and classifiers, BMC Bioinformatics, vol.11, p.594, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00624800

S. Decramer, A. Gonzalez-de-peredo, B. Breuil, H. Mischak, B. Monsarrat et al., Urine in clinical proteomics, Molecular & Cellular Proteomics, vol.7, pp.1850-1862, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00360866

R. Dissard, J. Klein, C. Caubet, B. Breuil, J. Siwy et al., Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice, PLoS One, vol.8, p.76703, 2013.

D. Fliser, J. Novak, V. Thongboonkerd, A. Argiles, V. Jankowski et al., Advances in urinary proteome analysis and biomarker discovery, Journal of the American Society of Nephrology, vol.18, pp.1057-1071, 2007.

S. Forterre, J. Raila, and F. J. Schweigert, Protein profiling of urine from dogs with renal disease using ProteinChip analysis, Journal of Veterinary Diagnostic Investigation, vol.16, pp.271-277, 2004.

D. M. Good, P. Zurbig, A. Argiles, H. W. Bauer, G. Behrens et al., Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease, Molecular & Cellular Proteomics, vol.9, pp.2424-2437, 2010.

P. Havanapan and V. Thongboonkerd, Are protease inhibitors required for gelbased proteomics of kidney and urine, Journal of Proteome Research, vol.8, pp.3109-3117, 2009.

J. A. Hokamp, R. E. Cianciolo, M. Boggess, G. E. Lees, S. L. Benali et al., Correlation of urine and serum biomarkers with renal damage and survival in dogs with naturally occurring proteinuric chronic kidney disease, Journal of Veterinary Internal Medicine, vol.30, pp.591-601, 2016.

N. Kampa, I. Bostrom, P. Lord, U. Wennstrom, P. Ohagen et al., Dayto-day variability in glomerular filtration rate in normal dogs by scintigraphic technique, Journal of Veterinary Medicine A, vol.50, pp.37-41, 2003.

N. Kampa, P. Lord, E. Maripuu, and A. Hoppe, Effects of measurement of plasma activity input on normalization of glomerular filtration rate to plasma volume in dogs, Veterinary Radiology & Ultrasound, vol.48, pp.585-593, 2007.

J. Klein, T. Papadopoulos, H. Mischak, and W. Mullen, Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine, Electrophoresis, vol.35, pp.1060-1064, 2014.

C. Lacroix, C. Caubet, A. Gonzalez-de-peredo, B. Breuil, D. Bouyssie et al., Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy, Molecular & Cellular Proteomics, vol.13, pp.3421-3434, 2014.

P. Magalhaes, M. Pejchinovski, K. Markoska, M. Banasik, M. Klinger et al., Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?, Scientific Reports, vol.7, p.16915, 2017.

H. Mischak, R. Apweiler, R. E. Banks, M. Conaway, J. Coon et al., Clinical proteomics: a need to define the field and to begin to set adequate standards, Proteomics Clinical Applications, vol.1, pp.148-156, 2007.

H. Mischak, G. Allmaier, R. Apweiler, T. Attwood, M. Baumann et al., Recommendations for biomarker identification and qualification in clinical proteomics, Science Translational Medicine, vol.2, pp.46-88, 2010.

H. Mischak, W. Kolch, M. Aivaliotis, D. Bouyssie, M. Court et al., Comprehensive human urine standards for comparability and standardization in clinical proteome analysis, Proteomics Clinical Applications, vol.4, pp.464-478, 2010.

H. Mischak, A. Vlahou, and J. P. Ioannidis, Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience, Clinical Biochemistry, vol.46, pp.432-443, 2013.

P. Monti, G. Benchekroun, D. Berlato, and J. Archer, Initial evaluation of canine urinary cystatin C as a marker of renal tubular function, The Journal of Small Animal Practice, vol.53, pp.254-259, 2012.

M. B. Nabity, G. E. Lees, L. J. Dangott, R. Cianciolo, J. S. Suchodolski et al., Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease, Veterinary Clinical Pathology, vol.40, pp.222-236, 2011.

M. B. Nabity, G. E. Lees, R. Cianciolo, M. M. Boggess, J. M. Steiner et al., Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy, Journal of Veterinary Internal Medicine, vol.26, pp.282-293, 2012.

M. B. Nabity, G. E. Lees, M. M. Boggess, M. Yerramilli, E. Obare et al., Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs, Journal of Veterinary Internal Medicine, vol.29, pp.1036-1044, 2015.

D. Polzin, Chronic kidney disease, Textbook of Veterinary Internal Medicine, pp.1938-1958, 2017.

K. Rossing, H. Mischak, P. Rossing, J. P. Schanstra, A. Wiseman et al., The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy, Proteomics Clinical Applications, vol.2, pp.997-1007, 2008.

J. P. Schanstra and H. Mischak, Proteomic urinary biomarker approach in renal disease: from discovery to implementation, Pediatric Nephrology, vol.30, pp.713-725, 2015.

J. P. Schanstra, P. Zurbig, A. Alkhalaf, A. Argiles, S. J. Bakker et al., Diagnosis and prediction of CKD progression by assessment of urinary peptides, Journal of the American Society of Nephrology, vol.26, 1999.
URL : https://hal.archives-ouvertes.fr/hal-01907604

G. Segev, C. Palm, B. Leroy, L. D. Cowgill, and J. L. Westropp, Evaluation of neutrophil gelatinase-associated lipocalin as a marker of kidney injury in dogs, Journal of Veterinary Internal Medicine, vol.27, pp.1362-1367, 2013.

J. Siwy, P. Zurbig, A. Argiles, J. Beige, M. Haubitz et al., Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis, Nephrology, Dialysis, Transplantation, vol.0, pp.1-11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01906007

M. Suthanthiran, J. E. Schwartz, R. Ding, M. Abecassis, D. Dadhania et al., Urinary-cell mRNA profile and acute cellular rejection in kidney allografts, The New England Journal of Medicine, vol.369, pp.20-31, 2013.

D. Theodorescu, S. Wittke, M. M. Ross, M. Walden, M. Conaway et al., Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis, The Lancet Oncology, vol.7, pp.230-240, 2006.

A. Wehner, K. Hartmann, and J. Hirschberger, Utility of serum cystatin C as a clinical measure of renal function in dogs, Journal of the American Animal Hospital Association, vol.44, pp.131-138, 2008.

F. Westgren, C. J. Ley, N. Kampa, and P. Lord, Effects of hydration on scintigraphic glomerular filtration rate measured using integral and plasma volume methods in dogs with suspected renal disease, Veterinary Radiology & Ultrasound, vol.55, pp.632-637, 2014.

P. Zurbig, M. B. Renfrow, E. Schiffer, J. Novak, M. Walden et al., Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation, Electrophoresis, vol.27, pp.2111-2125, 2006.